| David A Vermeersch, PHD | |
|
11130 Anderson St, Ste 117, Loma Linda, CA 92354-2802 | |
| (909) 558-8706 | |
| Not Available |
| Full Name | David A Vermeersch |
|---|---|
| Gender | Male |
| Speciality | Psychologist |
| Location | 11130 Anderson St, Loma Linda, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124139399 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY20684 (California) | Primary |
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation.
BioDiscovery, Inc., a leader in integrated software solutions for microarray-based research, and Exiqon A/S, a leader in microRNA analysis products and services, announced today an OEM Agreement incorporating BioDiscovery's array analysis and visualization software with Exiqon's arrays.
It was her love of ballet that led her to work with children who have motor disabilities. The retired dancer, now an occupational therapist, is pioneering a new "virtual" method to analyze movement patterns in children ― and more effectively treat those with debilitating motor disorders.
A Psychology and Neuroscience team of the University of Valencia has defined the specific neuropsychological profile of men with a history of violence against women in couple relationships who show several patterns of alcohol consumption.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David A Vermeersch, PHD 54701 File Number, Los Angeles, CA 90074-4701 Ph: (909) 558-3111 | David A Vermeersch, PHD 11130 Anderson St, Ste 117, Loma Linda, CA 92354-2802 Ph: (909) 558-8706 |
News Archive
The signing of a formal affiliation agreement that allows Kessler Foundation and New Jersey Health Foundation to work together to advance biomedical research, education and patient care programs has been announced by Rodger DeRose, president and chief executive officer of Kessler Foundation and James M. Golubieski, president of New Jersey Health Foundation.
BioDiscovery, Inc., a leader in integrated software solutions for microarray-based research, and Exiqon A/S, a leader in microRNA analysis products and services, announced today an OEM Agreement incorporating BioDiscovery's array analysis and visualization software with Exiqon's arrays.
It was her love of ballet that led her to work with children who have motor disabilities. The retired dancer, now an occupational therapist, is pioneering a new "virtual" method to analyze movement patterns in children ― and more effectively treat those with debilitating motor disorders.
A Psychology and Neuroscience team of the University of Valencia has defined the specific neuropsychological profile of men with a history of violence against women in couple relationships who show several patterns of alcohol consumption.
OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.
› Verified 7 days ago
Dr. Krystal Gregg, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Deborah Elizabeth Kessel Tallungan, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Behavioral Medicine Service (116a), Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Diane E. Bunker, Psychologist Medicare: Not Enrolled in Medicare Practice Location: Jerry L. Pettis Vamc, 11201 Benton Street, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Tori R. Van Dyk, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11130 Anderson St, Loma Linda, CA 92350 Phone: 909-553-7412 | |
Dorie-mae Nicolas, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 11441 San Juan St, Loma Linda, CA 92354 Phone: 917-562-1885 | |
William G Roth, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 11374 Mountain View Ave, Suite A, Loma Linda, CA 92354 Phone: 909-558-4505 |